Patterson Companies Inc. (NASDAQ:PDCO): After Paterson Companies reported results that beat consensus, Barrington noted the company’s 6% growth in sales of dental equipment and software was driven by CEREC and digital radiography products. Barrington thinks Patterson is well positioned to drive both growth and leverage and reiterates an Outperform rating and $36 price target on the stock.
Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): Wells Fargo said Teva’s reduced guidance removes an overhang on shares and the firm finds the stock’s valuation compelling at current levels. Wells thinks investors want more visibility on Copaxone patent infringement litigation in the near-term, but maintains an Outperform rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.